Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.988
+0.089 (9.93%)
Nov 21, 2024, 3:16 PM EST - Market closed

Barinthus Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-57.83-73.355.34-50.87-17.71-20.73
Depreciation & Amortization
2.612.231.120.40.210.35
Other Amortization
3.23.23.20.2--
Loss (Gain) From Sale of Assets
---0.35---0
Stock-Based Compensation
4.745.069.8816.493.630.83
Other Operating Activities
9.085.77-28.18.370.92-1.97
Change in Accounts Receivable
-14.975.8-5.830.560.48-0.96
Change in Accounts Payable
-2.44-3.381.14-3.530.592.97
Change in Unearned Revenue
2.04--0.18-0.06-0.030.21
Change in Other Net Operating Assets
-8.073.75-0.65-4.150.890.71
Operating Cash Flow
-61.63-50.93-14.43-32.58-11.03-18.68
Capital Expenditures
-0.46-5.41-6.14-1.15-0.29-0.13
Sale of Property, Plant & Equipment
--0.39--0
Cash Acquisitions
----11.77--
Investing Cash Flow
-0.46-5.41-5.75-12.91-0.29-0.12
Long-Term Debt Issued
----41.24-
Short-Term Debt Repaid
---0.16---
Total Debt Repaid
---0.16---
Net Debt Issued (Repaid)
---0.16-41.24-
Issuance of Common Stock
1.442.040.48102.77-0
Other Financing Activities
--0.16--5.270.192.04
Financing Cash Flow
1.441.870.33222.7441.442.04
Foreign Exchange Rate Adjustments
6.452.170.19-6.461.72-0.44
Net Cash Flow
-54.21-52.3-19.67170.7931.83-17.21
Free Cash Flow
-62.09-56.34-20.57-33.73-11.32-18.81
Free Cash Flow Margin
-414.79%-7024.69%-46.01%-12585.45%-234.83%-274.80%
Free Cash Flow Per Share
-1.59-1.47-0.54-1.30-1.43-801.48
Cash Interest Paid
---1.840-
Cash Income Tax Paid
---0.15--
Levered Free Cash Flow
-50.75-42.351.64-16.54-7.14-
Unlevered Free Cash Flow
-50.72-42.331.65-14.87-4.89-
Change in Net Working Capital
21.78-2.854.615.05-2.05-
Source: S&P Capital IQ. Standard template. Financial Sources.